NEW YORK APTO IN FIFTIES - AIMS, PHILOSOPHY AND METHODS OF APTO

被引：0
|
作者：
不详
机构：
来源：
INTERNATIONAL JOURNAL OF OFFENDER THERAPY | 1971年 / 15卷 / 02期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：88 / 92
页数：5
相关论文
共 50 条
  • [1] NEW YORK APTO IN FIFTIES - DELINQUENCY WORK IN PARISH
    不详
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (02): : 110 - 112
  • [2] NEW YORK APTO IN FIFTIES - ETHICAL VALUES AND PSYCHOTHERAPY
    不详
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (02): : 108 - 118
  • [3] NEW YORK APTO IN FIFTIES - SPECIAL TECHNIQUES IN TREATING YOUNG OFFENDER
    不详
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (02): : 93 - 105
  • [4] NEW YORK APTO IN FIFTIES - NOTION OF UNCONSCIOUS GUILT AND ITS EFFECTS ON THERAPY
    不详
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (02): : 112 - 113
  • [5] NEW YORK APTO IN FIFTIES - CHANGING PATIENTS SELF-CONCEPT AS A STEP IN THERAPY
    不详
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (02): : 106 - 107
  • [6] FROM NEW YORK APTO - SPECIAL PROBLEMS IN TREATING FEMALE OFFENDERS - CLARIFYING PATIENTS SENSE OF IDENTITY
    MILSTEIN, F
    [J]. INTERNATIONAL JOURNAL OF OFFENDER THERAPY, 1971, 15 (01): : 16 - 20
  • [7] 'New York in the Fifties'
    Quart, L
    [J]. CINEASTE, 2001, 26 (02): : 64 - 64
  • [8] APTO-253 Is a New Addition to the Repertoire of Drugs that Can Exploit DNA BRCA1/2 Deficiency
    Tsai, Cheng-Yu
    Sun, Si
    Zhang, Hongying
    Local, Andrea
    Su, Yongxuan
    Gross, Larry A.
    Rice, William G.
    Howell, Stephen B.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2018, 17 (06) : 1167 - 1176
  • [9] APTO-253 is a new addition to the repertoire of drugs that can exploit DNA BRCA1/2 deficiency
    Tsai, Cheng-Yu
    Sun, Si
    Zhang, Hongying
    Local, Andrea
    Rice, William
    Howell, Stephen B.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [10] Comparative philosophy: Its aims and methods
    Fleming, J
    [J]. JOURNAL OF CHINESE PHILOSOPHY, 2003, 30 (02) : 259 - 270
12345